<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TIOTROPIUM BROMIDE</span><br/>(ti-o-tro'pi-um)<br/><span class="topboxtradename">Spiriva<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">anticholinergic</span>; <span class="classification">parasympatholytic</span>; <span class="classification">antimuscarinic</span>; <span class="classification">antispasmodic</span><br/><b>Prototype: </b>Ipratropium<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>18 mcg capsules with powder for inhalation</p>
<h1><a name="action">Actions</a></h1>
<p>A long-acting, antispasmodic agent. In the bronchial airways, it exhibits inhibition of muscarinic receptors of the smooth
         muscle resulting in bronchodilation. The drug effect can last up to 24 h.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Bronchodilation after inhalation of tiotropium is predominantly a site-specific effect.</p>
<h1><a name="uses">Uses</a></h1>
<p>Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to tiotropium, atropine, or ipratropium; pregnancy (category C); children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Decreased renal function; BPH, urinary bladder neck obstruction; narrow-angle glaucoma; older adults; lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">COPD</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Inhaled</span> Inhale the contents of one capsule once daily using hand inhaler device provided.<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Inhalation</span><br/><ul>
<li>Place capsule in HandiHaler® and press button to puncture. Instruct patient to exhale deeply then put the mouthpiece
            to the lips and breathe in the dose deeply and slowly; remove HandiHaler® and hold breath for at least 10 sec, and then
            exhale slowly; rinse mouth with water to minimize dry mouth.
         </li>
<li>Ensure that drug does not contact the eyes.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Nonspecific chest pain, dependent edema, infection, moniliasis, flu-like syndrome, cough, allergic reactions. <span class="typehead">CNS<b></b> 			:</span> Dysphonia, paresthesia, depression. <span class="typehead">GI<b></b> 			:</span> Abdominal pain, constipation, <span class="speceff-common">dry mouth</span> <i>,</i> dyspepsia, vomiting, reflux, stomatitis. <span class="typehead">Metabolic<b></b> 			:</span> Hypercholesterolemia, hyperglycemia. <span class="typehead">Musculoskeletal<b></b> 			:</span> Myalgia, skeletal pain. <span class="typehead">Respiratory<b></b> 			:</span> Epistaxis, pharyngitis, rhinitis, laryngitis, <span class="speceff-common">sinusitis, upper respiratory tract infection</span> <i>.</i> <span class="typehead">Skin<b></b> 			:</span> Rash. <span class="typehead">Special Senses:</span> Cataract. <span class="typehead">Urogenital<b></b> 			:</span> Urinary tract infection. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug<b></b> 			:</span> May cause additive anticholinergic effects with other <span class="classification">anticholinergic agents</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption<b></b> 			:</span> 19.5% absorbed from the lungs. <span class="typehead">Peak<b></b> 			:</span> 5 min. <span class="typehead">Metabolism<b></b> 			:</span> Elimination<b></b> 			: 14% of dose excreted in urine; remaining is excreted in feces as nonabsorbed drug. <span class="typehead">Half-Life:</span> 56 d. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Withhold drug and notify physician if S&amp;S of angioedema occurs.</li>
<li>Monitor for anticholinergic effects (e.g., tachycardia, urinary retention).</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not allow powdered medication to contact the eyes, as this may cause blurring of vision and pupil dilation.</li>
<li>Tiotropium bromide is intended as a once-daily maintenance treatment. It is not useful for treatment of acute episodes of
            bronchospasm (i.e., rescue therapy).
         </li>
<li>Withhold drug and notify physician if swelling around the face, mouth, or neck occurs.</li>
<li>Report any of the following: constipation, increased heart rate, blurred vision, urinary difficulty.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>